Our profiling and comparison of the steps of conolidine and cannabidiol with known pharmacological agents predicted a MOA shared with Cav2.2 channel blocker, ω-conotoxin CVIE. In 2011, the halls in the Scripps Exploration Institute in Jupiter, Florida witnessed the inception of the scientific journey that may redefine our understanding https://romainy017iki0.bligblogging.com/profile